IntegraMed® Expands Southeastern Florida Presence with Opening of New Vein Clinic in Boca Raton, Florida

BOCA RATON, Fla.--(BUSINESS WIRE)--IntegraMed America, Inc. (NASDAQ: INMD), the leading operator of fertility centers and vein clinics in the United States, today announced the opening of its Boca Raton Vein Clinic, IntegraMed’s third vein clinic in Southeastern Florida and its 29^th vein clinic in the U.S. The Vein Clinics of America Boca Raton location is led by phlebologist Dr. Christopher Perez. The facility, which commenced patient visits on February 19th, is located at 5550 Glades Road, Suite 210, just west of Interstate 95. The phone number is 561/750-2251, and more information is available at http://www.veinclinics.com/vcaflorida/bocaraton.html

Kush Agarwal, President of IntegraMed’s Vein Clinics division, commented, “Christopher Perez is a highly accomplished physician and skilled phlebologist who brings tremendous experience and compassion to the task of treating vein disease. Working from this newly completed, state-of-the-art clinic, outfitted with the latest in laser and other vein treatment technologies, Dr. Perez and his team are uniquely positioned to deliver the highest level of patient care available in the area. The demographics of Boca Raton, with its substantial community of adults nearing or already in retirement, provides a population that has needed a focused vein care solutions provider of this caliber. We are pleased to bring this capability to this community, building on our already successful Vein Clinics of America locations in Fort Lauderdale and West Palm Beach.”

Dr. Perez earned his medical degree from the University of Michigan and served his residency at St. Luke’s-Roosevelt Medical Center in New York. He is board certified in emergency medicine and is a Major in the United States Army Medical Corps. Dr. Perez is proficient in Endovenous Laser Treatment (ELT), a minimally invasive, outpatient laser treatment. Dr. Perez is also highly accomplished in VCA’s published treatment protocol, COMPASS(sm) (Comprehensive Objective Mapping, Precise Image Guided Injection, anti-reflux Positioning and Sequential Sclerotherapy), which has been described as a “safe and highly efficacious” technique in the management of extensive large vein disease.

About Vein Clinics of America, Inc.

Established in 1981, Vein Clinics of America, Inc. (VCA) is the largest medical group in the country dedicated to the non-surgical treatment of vein disorders. The physicians of VCA specialize in treating the entire spectrum of vein abnormalities, including varicose veins, spider veins, venous leg ulcers, facial veins, hand veins, Klippel-Trenaunay Syndrome and Restless Legs Syndrome resulting from venous reflux. VCA, a wholly owned subsidiary of IntegraMed America, is based in Downers Grove, IL with operations in Florida, Georgia, Illinois, Indiana, Kansas, Maryland, Missouri, North Carolina, Kansas, Virginia and Wisconsin, and operates www.veinclinics.com, a leading vein care portal.

About IntegraMed America, Inc.

IntegraMed America, Inc. is the leading operator of fertility centers and vein care clinics in the United States. The Company supports its provider networks with state-of-the art information systems; marketing and payer contracting; financial planning, reporting and analysis; organizational planning and development; quality assurance initiatives; human resources administration; and purchasing services. IntegraMed also offers consumer treatment-financing programs and operates www.integramed.com, a leading fertility portal.

The IntegraMed Fertility network consists of 29 contracted centers in 96 locations across the United States, including 166 physicians and Ph.D. scientists. One of every five IVF procedures in the U.S. is performed in an IntegraMed fertility practice. The IntegraMed Vein Clinic network is the leading provider of vein care services in the US and operates 29 centers in 11 states, principally in the Midwest and Southeast.

Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed are forward-looking statements that may involve a number of risks and uncertainties. Actual results may differ materially from the statements made as a result of various factors, including, but not limited to, the risks associated with IntegraMed's ability to finance future growth; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the company's most recent Form 10-K and in other documents filed by IntegraMed with the U.S. Securities and Exchange Commission. All information in this press release is as of February 26, 2008 and IntegraMed undertakes no duty to update this information.